Allogeneic hematopoietic stem cell transplantation in germline DDX41 mutated patients with myeloid malignancies.
Loschi M, Villy MC, Galimard JE, Auboiroux MM, Gachard N, Perani A, Duchmann M, Largeaud L, Nguyen S, Sicre de Fontbrune F, Robin M, Yakoub-Agha I, Daguindau E, Chantepie SP, Charbonnier A, Lebon D, Maury S, Labussiere-Wallet H, Huynh A, Forcade E, Castilla-Llorente C, Cluzeau T, Adès L, D'Aveni M, Devillier R, Maillard N, Benachour S, Dombret H, Récher C, Pigneux A, Clappier E, Delabesse E, Duployez N, Turlure P, Peffault De Latour R, Sebert M.
Loschi M, et al. Among authors: lebon d.
Blood Adv. 2025 Sep 9:bloodadvances.2025017084. doi: 10.1182/bloodadvances.2025017084. Online ahead of print.
Blood Adv. 2025.
PMID: 40924929